Lung cancer is the leading cause of cancer-related mortality in the United States. Only 15% of patients with this disease survive 5 years or longer. Early metastatic spread is the single most important reason for this poor outcome. The survival of patients with pathological stage I disease, that is, no evidence for metastatic spread, and molecular aberrations on chromosome 11p15.5 is equal to that of patients with stage II disease, that is, metastatic spread to hilar lymph nodes. RRM1 is a gene in this region, and it is haploinsufficient in at least 34% stage I patients. Here, we show that overexpression of RRM1 in human and mouse lung cancer cell lines induced PTEN expression, reduced phosphorylation of focal adhesion kinase (FAK), suppressed migration, invasion, and metastasis formation, and increased survival in an animal model. Increased PTEN expression was required for the RRM1-induced suppression of cell motility and FAK phosphorylation. We conclude that RRM1 functions as a metastasis suppressor gene through induction of PTEN expression.
Introduction
Lung cancer is estimated to cause more death (154 900) than colorectal cancer (56 600), breast cancer (40 000), and prostate cancer (30 200) combined in the United States in 2002 (Jemal et al., 2002) . The four major histologic subtypes, small-cell carcinoma (SCLC), squamous cell carcinoma, adenocarcinoma, and large-cell carcinoma, account for 21.2, 31.4, 34.9, and 10.9% of all new lung cancer cases (Surveillance, Epidemiology, and End Results database cases from 1983 to 1992). Improvement in 5-year survival rates have paralleled those for all cancers combined since the 1960s; they remain, however, among the lowest with a 5-year survival of 15% in the 1990s (Jemal et al., 2002) . This is most likely attributable to early metastatic dissemination even in non small-cell carcinomas (NSCLC). This is supported by the observation that more than 70% of relapses in stage I disease (a single primary tumor located within one lobe of the lung without microscopic evidence for disease in hilar or mediastinal lymph nodes) after complete surgical resection occur at distant sites (Jaklitsch et al., 1995) .
We have reported frequent allele loss on human chromosome 11p15.5 and its association with metastatic spread in patients with lung cancer (Bepler et al., 1998; Bepler and Garcia-Blanco, 1994) . We also recently reported the completed sequence and transcripts from this region (GenBank Accession numbers AF 391283-5), and that patients with resected stage I NSCLC and allele loss had a survival similar to resected stage II patients (Zhao and Bepler, 2001, Bepler et al., 2002) . Together, these results suggested that this region contains a gene involved in the regulation of metastasis formation. Here we report that the RRM1 gene, which is located in this region, suppresses invasion, migration, and in vivo metastasis formation through upregulation of the PTEN tumor-suppressor gene, when overexpressed in human and mouse lung cancer cell lines.
Results

RRM1 overexpression inhibits cell motility
The human adenocarcinoma of the lung-derived cell line NCI-H23 (ATCC #CRL-5800) was stably transfected with two human RRM1 cDNA constructs. The investigational cell line contained the transgene in-frame (H23-R1), the control cell line contained the transgene out-of-frame (H23-Ct), and both were under the control of a CMV promoter. To confirm that RRM1 overexpression occurred in cell line H23-R1, we compared its RNA and protein expression with that of H23-Ct. The observed average level of RNA overexpression was 2. 2-fold (2.1970.16) (Figure 1a ) and the level of protein overexpression was 2.8-fold (2.8470.24) (Figure 1b ). This was confirmed using realtime quantitative PCR (Table 1) in multiple serial passages and in clonal sublines of H23-R1 that were generated by serial dilution.
Cell migration and invasion were studied in Boyden blind well chambers with polycarbonate filters of 13 mm diameter and 10 mm pore size. We found that the number of migrated cells was reduced by 48% in H23-R1 (119720 cells/field) compared with H23-Ct (2297 18 cells/field) (Figure 2a) . A 41% inhibition of cell invasion was also observed in H23-R1 (103715) compared with H23-Ct (174719) (Figure 2b ).
RRM1 overexpression does not alter dNTP levels
Since RRM1 is one of the two components of ribonucleotide reductase, whose cellular function is to provide the deoxynucleotides required for DNA synthesis and repair through catalysis of ribonucleoside diphosphates to the corresponding deoxyribonucleosides (Elledge et al., 1992; Stubbe, 1998) , we assessed whether RRM1 overexpression would alter the total deoxynucleotide pool or cause imbalances among the respective deoxynucleotides. We used a method that measures total cellular dNTP levels indirectly through [ 3 H] dNTP incorporation in a polynucleotide template. With this method, we did not find differences in the total amount of dNTPs or the relative distribution of dNTPs between H23-R1 and H23-Ct (Figure 3 ). To confirm that RRM1 overexpression does not alter dNTP pools, we used hydroxyurea and gemcitabine to inhibit ribonucleotide reductase function. If RRM1 overexpression causes a change in absolute or relative dNTP levels, one would expect to see differential sensitivity to these agents between H23-Ct and H23-R1. Hydroxyurea specifically inactivates the tyrosyl radical in the catalytic subunit (RRM2) of ribonucleotide reductase, and it does not interfere with the regulatory subunit (RRM1). This is a result of a reduction of Fe 3+ to Fe 2+ in the binuclear iron center, which is required for catalysis Figure 1 RNA and protein levels of the human adenocarcinoma of the lung cell line NCI-H23 transfected with an out-of-frame cDNA construct (H23-Ct) and an in-frame cDNA construct (H23-R1). (a) Northern analysis of total RNA probed with GAPDH, RRM1, and PTEN. RRM1 and PTEN were both overexpressed 2.2-fold in H23-R1 compared to H23-Ct. (b) Western analysis of cell lysates probed with antibodies specific for b-actin, RRM1, PTEN, total FAK, and phosphorylated FAK. RRM1 and PTEN were overexpressed 2.8-fold and 2.7-fold in H23-R1. FAK expression was equal but FAK phosphorylation was reduced by 53% in H23-R1 compared to H23-Ct Figure 2 Migration (a) and invasion (b) assays with H23-Ct and H23-R1 with and without PTEN antisense oligonucleotide treatment are shown. AS1 and AS2 were two different antisense oligonucleotides, C18 and C21 were two nonspecific control oligonucleotides, and CS was a PTEN sense oligonucleotide corresponding to AS2. The number of migrated or invaded cells in five random fields of each filter was counted after 72 h in a microscope. Values of migrated or invaded cells are means7s.d. from triplicate determinations (Nyholm et al., 1993) . Cytotoxicity was assessed with the sulforhodamine B assay over a concentration range of 1 mm-100 mm for hydroxyurea and of 10 pm-1 mm for gemcitabine. We did not observe a difference in the sensitivity of both cell lines to these agents (data not shown). These data strongly suggest that RRM1 overexpression does not alter dNTP pools.
RRM1 overexpression induces PTEN expression and reduces FAK phosphorylation
To obtain data on RRM1-regulated targets that may provide leads into pathways that connect cell motility with RRM1 function, we used oligonucleotide and cDNA microarrays. One of the genes differentially expressed between the two cell lines was PTEN. It was expressed approximately twofold higher in H23-R1 cells compared to H23-Ct cells. PTEN is a dual-specificity phosphatase, and its overexpression had been shown to inhibit cell migration (Tamura et al., 1998) . Owing to this similarity with the RRM1-induced phenotype, we compared PTEN expression between H23-R1 and H23-Ct at the RNA and protein level. In Northern blots PTEN was expressed 2.2-fold (2.2270.29) higher ( Figure 1a ) and in Western blots 2.7-fold higher in H23-R1 compared with H23-Ct (Figure 1b) . The relation between RRM1 and PTEN expression was confirmed in serial passages and clonal sublines of H23-R1 (Table 1) .
Since focal adhesion kinase (FAK) is an important downstream molecule of PTEN-induced motility inhibition (Gu et al., 1999; Tamura et al., 1999b) , we assessed its expression and found no difference in RNA (1.2370.12) (data not shown) or protein (0.9270.13) (Figure 1b ) levels between both the cell lines. However, phosphorylation of FAK was significantly reduced (53%) in H23-R1 compared to H23-Ct (Figure 1b ). This suggested that RRM1 decreases FAK phosphorylation through the PTEN pathway; however, a PTENindependent effect of RRM1 on FAK phosphorylation cannot be excluded.
PTEN is required for the RRM1 induced motility inhibition
In order to demonstrate that the RRM1-induced inhibition of cell motility and FAK phosphorylation require PTEN, we employed PTEN antisense oligonucleotides. Treatment of H23-R1 cells with two different PTEN antisense oligonucleotides (AS1 and AS2) completely abolished the observed migration and invasion inhibition, whereas three different control oligonucleotides, a nonspecific 18-mer (C18), a nonspecific 21-mer (C21), and a PTEN sense oligonucleotide, did not affect the number of migrated (Figure 2a ) or invaded cells (Figure 2b ). PTEN protein levels in H23-R1 treated with both antisense oligonucleotides were reduced and comparable to those seen in H23-Ct cells (Figure 4 ). In addition, FAK phosphorylation was restored while RRM1 levels remained unchanged. The three control oligonucleotides did not alter PTEN protein levels or FAK phosphorylation. These results confirm that the RRM1-induced cell motility changes and FAK phosphorylation require PTEN expression, and the magnitude of overexpression required for this inhibition is consistent with the reported result that a twofold overexpression of PTEN RNA significantly reduced cell migration in an in vitro wound healing assay (Tamura et al., 1998) .
Our results on RNA and protein expression of PTEN clearly show that this gene is not homozygously deleted or completely transcriptionally silenced through other mechanisms in NCI-H23; however, haploinsufficiency or mutations in one or all alleles remained as possible mechanisms of PTEN attenuation. To study this possibility, we sequenced the 1212 bp coding region of PTEN in cell line NCI-H23 using the published cDNA sequence (GenBank Accession number U 92436) as a reference. Six primers were used for cycle sequencing in both directions of cDNA generated from total RNA. The sequences obtained were 100% identical with the published PTEN sequence. There was no ambivalence in the nucleotides suggesting that the PTEN alleles in NCI-H23 are homozygous and identical. In addition, there was no evidence for synchronous amplification of the PTEN2 pseudogene (GenBank Accession number AF 017999). Finally, we confirmed the identity of the parent cell line, NCI-H23, and the transfectants, H23-R1 and H23-Ct, by spectral karyotyping (Schrock et al., 1996) . A total of 50 metaphases from each cell line were prepared and analysed, and they were consistent with the reported G-banding karyotype of NCI-H23 (Whang-Peng et al., 1991) . In addition, we did not find unique differences between the parent cell line and the transfectants.
RRM1 overexpression inhibits spontaneous metastasis formation in a syngeneic mouse lung cancer model
Next, we investigated if RRM1 overexpression would influence spontaneous metastasis formation in vivo using a syngeneic lung carcinoma animal model. Line1 is an adenocarcinoma of the lung that spontaneously arose in a Balb/c mouse. It forms subcutaneous tumors within 2 weeks of injection and spontaneously metastasizes to the lung. This cell line was stably transfected with the inframe (Line1-R1) and out-of-frame (Line1-Ct) human RRM1 cDNA expression vectors, and overexpression was confirmed as described for cell line NCI-H23. Three cohorts of 3-week-old Balb/c mice were subcutaneously injected with 100 000 cells per mouse of the parental cell line and the two transfected cell lines. Subcutaneous tumor formation occurred in all the three cohorts within 2 weeks. All mice injected with Line1 or Line1-Ct developed deep cutaneous ulcers at the site of subcutaneous tumor growth by week 4, while none of the mice carrying Line1-R1 tumors developed ulcers despite tumors reaching similar sizes (data not shown). Animals were killed after 3 and 6 weeks, and the lungs were inspected for metastasis formation by gross and microscopic examination. Metastases in the lungs were not found in the three cohorts 3 weeks after injection ( Figure 5 ). Five out of eight animals had developed lung metastases in the control groups 6 weeks after injection, the number of metastatic foci ranged from 1 to 6 and there was no difference between the parent cell line (Line1) and the transfected control cell line (Line1-Ct) ( Figure 5 ). In contrast, only one out of the seven mice injected with Line1-R1 had developed a single metastatic focus in the lung. The liver and brain was also examined for metastatic foci after 6 weeks, and none were found. This shows that RRM1 overexpression is capable of suppressing spontaneous in vivo metastasis formation in an animal model of an adenocarcinoma of the lung.
RRM1 overexpression increases survival in a syngeneic mouse lung cancer model Finally, we measured the effect of RRM1 overexpression on survival using the same syngeneic lung carcinoma animal model. For this, two groups of seven mice each were injected with Line1-R1 and Line1-Ct subcutaneously, and the day of death was recorded for each animal until day 120. As shown in Figure 6 , the first Line1-Ct animal died on day 23, and all were dead by day 73. In contrast, the first death in the Line1-R1 animals occurred on day 74, and one animal survived more than 120 days. Kaplan-Meier survival curves were generated and are indistinguishable from the actual survival curves (data not shown). This difference in survival was highly significant (P ¼ 0.0006, log-rank test). At the time of death lung metastases were found in all animals, but liver metastases were only found in two of the control animals. These results show that RRM1 overexpression not only reduces spontaneous metastasis formation but also substantially prolongs survival in an experimental animal model.
Discussion
Previous studies had shown an association between chromosome 11p15.5 allele loss and metastasis formation and poor survival in patients with lung cancer (Bepler et al., 1998 (Bepler et al., , 2002 . One of the genes in the deleted region is RRM1 (Pitterle et al., 1999; Zhao and Bepler, 2001) , and stable expression of a biologically Figure 5 Balb/c mice were subcutaneously injected at a single site with the syngeneic lung adenocarcinoma cell line Line1 and the two transgene-carrying cell lines Line1-Ct and Line1-R1. These lines had been stably transfected with the in-frame (Line1-R1) and outof-frame (Line1-Ct) human RRM1 cDNA constructs. Lung metastasis formation is shown 3 and 6 weeks after subcutaneous injection of 100 000 cells. No metastases were found after 3 weeks. Arrows point at metastases after 6 weeks in the parent cell line and control cell line, and no metastases were found in Line1-R1
RRM1 and PTEN A Gautam et al active ectopic RRM1 in a ras-transformed mouse fibroblast cell line resulted in reduced anchorageindependent growth and tumor formation in syngeneic mice (Fan et al., 1997) . A decrease in invasiveness had also been reported for an RRM1-transfected human oropharyngeal carcinoma cell line (Zhou et al., 1998) . Likewise, genetic complementation of human lung carcinoma cell lines with a whole chromosome 11 or radiation-reduced chromosomal fragments that contained the human RRM1 gene resulted in suppression of xenograft formation (Satoh et al., 1993; O'Briant et al., 1997) . These results suggested a role for RRM1 in the phenotypic behavior of malignant cells that was distinct from its well-known role in the formation of the enzyme ribonucleotide reductase. Here we show that a two to threefold overexpression of the human RRM1 gene in human and mouse lung cancer cell lines resulted in inhibition of in vitro motility and in vivo metastasis formation, which requires increased expression of the tumor suppressor gene PTEN. PTEN was originally identified by positional cloning in a region of frequent allele loss on chromosome 10q23 in breast and brain tumors Steck et al., 1997) and simultaneously through functional cloning of TGF-b responsive genes (Li and Sun, 1997) . It is rarely deleted or mutated in NSCLC (Forgacs et al., 1998) ; however, transcriptional silencing through DNA methylation has been suggested as an alternate mechanism for PTEN inactivation in lung cancer (Soria et al., 2002) and gastric carcinoma (Kang et al., 2002) . Our results on PTEN expression and mutation analysis in NCI-H23 indicate that this gene is not inactivated through homozygous deletion or other mechanisms of transcriptional silencing, which is consistent with published reports that homozygous deletions are absent in NSCLC (0/61) (Forgacs et al., 1998) . This is of interest given the relatively frequent allele loss (41%) of polymorphic loci near PTEN in NSCLC , and it suggests that the PTEN locus is not involved in the allele loss. However, Forgacs et al. reported homozygous alterations of the amino-acid sequence in 3/18 NSCLC cell lines. One of these was the cell line used in our investigation, NCI-H23, and it had a reported transition of C to T in the first position of codon 233 (nucleotide 1731 in U92436), which resulted in a premature stop codon (TGA). This would result in a truncation of PTEN from 403 to 232 amino acids. We were unable to confirm this mutation and truncation in our parent line, and we confirmed the identity of our cell line by spectral karyotyping. Thus, the cell line used in our experiments expresses wild-type and functional PTEN without evidence for sequence variations. A possible explanation for this data discrepancy is a clonal drift between the parent cell lines used. Another possibility is that the primers used in the publication by Forgacs et al. (PT631 s and PT859 ) may have generated spurious results as a result of a nucleotide deletion in the forward primer.
PTEN is involved in the regulation of multiple cellular functions including adhesion, motility, apoptosis, cell cycle progression, and signal transduction (Maehama and Dixon, 1998; Ramaswamy et al., 1999; Sun et al., 1999; Weng et al., 2001) .
Overexpression of PTEN inhibited cell migration, whereas PTEN antisense enhanced migration (Tamura et al., 1998; Tamura et al., 1999b; Hong et al., 2000) . These results were corroborated with isogenic PTEN +/+ and PTEN À/À mouse fibroblast lines (Liliental et al., 2000) . At least part of PTEN's ability to suppress cell migration and invasion is mediated through dephosphorylation of FAK (Gu et al., 1999; Tamura et al., 1999a) .
In the present study, an approximately twofold increased expression of RRM1 in H23-R1 cells resulted in a 2.2-fold increase in PTEN RNA and a corresponding 2.7-fold increase in PTEN protein expression compared to H23-Ct cells. Cell migration and invasion were markedly decreased in H23-R1 cells compared to H23-Ct cells, and they were completely restored with the use of PTEN antisense. This indicates that the RRM1-induced inhibition of cell motility requires elevated expression of PTEN. The magnitude of the PTEN overexpression required for this inhibition is consistent with the reported result that a twofold overexpression of PTEN RNA significantly reduced cell migration in an in vitro wound-healing assay (Tamura et al., 1998) .
Which of PTEN's pleiotropic downstream effectors are essential for the motility-inhibitory effect? Published reports suggest that it is the tyrosine kinase FAK, a regulator of integrin-dependent signaling and cell migration (Tamura et al., 1998 (Tamura et al., , 1999a . PTEN directly interacts with FAK and reduces its tyrosine phosphorylation. FAK expression is enhanced in proliferating cells during wound healing (Gates et al., 1994; Romer et al., 1994) , and FAK overexpression stimulates cell migration (Cary et al., 1996) . Cells in which FAK is inhibited by tyrosine kinase inhibitors, cells from FAK knockout mice, and cells overexpressing a dominantnegative FAK mutant all exhibit decreased cell migration (Romer et al., 1994; Ilic et al., 1995 ; Gilmore and Figure 6 Actual survival of Balb/c mice injected subcutaneously with Line1-Ct and Line1-R1. The survival difference is significant at P ¼ 0.0006. Local tumor formation was first observed on day 14 in both groups of animals. The first evidence for lung metastases in Line1-Ct animals was on day 23 and in Line1-R1 animals on day 39 Romer, 1996) . We examined whether FAK phosphorylation correlated with the effects of RRM1 on cell migration and invasion. Western analysis showed a decrease in FAK phosphorylation in H23-R1 compared with H23-Ct without alteration of FAK protein expression. In addition, PTEN antisense treatment of H23-R1 cells restored FAK phosphorylation levels to those observed in the control cells H23-Ct. Taken together, these results suggest that FAK dephosphorylation is a major contributor to the observed motility inhibition.
However, other effectors may be involved in the RRM1-induced and PTEN-mediated suppression of cell migration and invasion. For instance, Rho-like GTPases are thought to be involved in cellular migration and invasion through reorganization of the actin cytoskeleton (Hall, 1998; Schmitz et al., 2000) , and it has recently been reported that deletion of PTEN promotes cell motility by activation of Rac1 and Cdc42 (Liliental et al., 2000) . The result that RRM1 overexpression does not impact on dNTP levels strongly suggests that the observed phenotype is not a result of DNA damage caused by disturbance in deoxynucleotide pools (Allen et al., 1994; Desany et al., 1998) . Finally, the mechanism by which RRM1 induces expression of PTEN is unclear. Several different possibilities exist, and they are being investigated. Since RRM1 has no known transcription factor motifs, it is unlikely that a direct transcriptional activation of the PTEN gene is responsible for the observed increase in message and protein. One possible connection between RRM1 and PTEN is through TGF-b. Interestingly, in one of the original descriptions of PTEN, it was identified as a TGF-b regulated gene (Li and Sun, 1997) . RRM1 has an element in the 3 0 -untranslated region that appears to be involved in message stability, and it is responsive to TGF-b (Chen et al., 1993; Amara et al., 1996) . It is thus conceivable that the increased levels of RRM1 in H23-R1 cells result in increased availability of a factor that is involved in the regulation of PTEN message.
We conclude that RRM1, aside from its role in the generation of deoxyribonucleoside diphosphates, which is essential for DNA synthesis and repair (Cory and Sato, 1983; Reichard, 1993; Tanaka et al., 2000) , has an essential role in cellular motility through increased PTEN expression.
Materials and methods
Transfection of cell lines
The human adenocarcinoma of the lung cell line NCI-H23 and the mouse cell line Line1 have been described previously (Yuhas et al., 1975; Carney et al., 1985) . They were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). All experiments were carried out using exponentially growing cells. The lines were free from mycoplasma (GEN-PROBE Inc., San Diego, CA, USA). Cells were transfected with a full-length human RRM1 cDNA cloned into the expression plasmid pCMV-Tag2 (Stratagene, La Jolla, CA, USA). Cell lines H23-Ct and Line1-Ct were transfected with a vector containing the gene out-of-frame and H23-R1 and Line1-R1 with a vector containing the gene in-frame. Clonal sublines of H23-R1 were generated by serial dilution in 96-well plates. All cell lines were maintained in RPMI 1640 medium containing 10% FBS and 400 mg/ml of G418.
In vitro motility assays
Migration was assayed using Boyden blind well chambers with polycarbonate filters of 13 mm diameter and 10 mm pore size, following the manufacturer's instructions (NeuroProbe, Inc. Gaithersburg, MD, USA). The filters divided the chamber into a lower compartment containing RPMI with 10% FBS and an upper compartment containing the cell suspension (10 000 cells/ml) in RPMI with 0.3% bovine serum albumin (BSA). Chambers were incubated at 371C for 22 h. Filters were then removed, cells on the upper surface were wiped off, and cells that had migrated to the lower surface were fixed and stained with hematoxylin and eosin. The number of migrated cells on each filter was counted in five random fields at highpower magnification. For invasion assays, filters were coated with a mixture of laminin (50 mg/ml), type IV collagen (50 mg/ ml), and gelatin (2 mg/ml) in 10 mm glacial acetic acid solution. Everything else was as described for the migration assay.
Deoxynucleotide pool assessment
For the measurement of total cellular dNTP levels, nucleotides were extracted from 2 Â 10 6 exponentially growing cells by scraping them into ice-cold 60% methanol. Lysates were stored overnight at À201C, and cell debris was removed by centrifugation. The supernatant was dried and the dNTPs (pellet) dissolved in H 2 O. Respective dNTP levels were determined by measuring the incorporation of complementary [ 3 H] dNTPs into poly d(A-T) or poly d(I-C) templates by Klenow using 1/10th of the cell lysate solution. For cytotoxicity assessment with the drugs hydroxyurea and gemcitabine, exponentially growing cells were seeded in 96-well plates. A total of 11 different concentrations over a range of 5 logs were tested. Each concentration was represented by eight wells, and the eight remaining wells contained only growth medium, but no cells. Exposure to drug was in complete growth medium for 5 days (hydroxyurea) and 6 days (gemcitabine). After addition of sulforhodamine, the absorbance was determined at 560 nm in a plate reader.
PTEN antisense experiments
Two PTEN antisense (AS1 and AS2), two nonspecific control (C18 and C21), and one PTEN control sense (CS) phosphorothioate oligonucleotides were synthesized. The sequences were GCTCA ACTCT CAAAC TTCCA T for AS1, CGGCG GCGGG TCTCT CATCT C for AS2, TGGAT CCGAC ATGTC AGA for C18, ATGGA AGTTT GAGAG AGTTG A for C21, and GAGAT GAGAG ACGGC GGCGG C for CS. CS is the corresponding sense sequence to AS2. They were dissolved in RPMI 1640 medium at 100 mm. H23-Ct or H23-R1 cells were plated in 6-well plates (25000 cells/well) in RPMI 1640 medium with 10% FBS and 400 mg/ml G418. The oligonucleotides were mixed with Lipofectin (Gibco, Gaithersburg, MD, USA), incubated at 371C for 15 min, diluted with medium, and added to the cells at a final concentration of 1 mm of oligonucleotide and 3 mg/ml of Lipofectin. Fresh oligonucleotide-containing medium was added daily to the cells. Cells were harvested after 72 h with trypsin.
Sequencing of PTEN
For sequencing of the human PTEN gene in cell line NCI-H23, cDNA was prepared from total RNA. The complete PTEN coding sequence as reported in GenBank Accession number U 92436 was used as a reference. The entire coding sequence of 1212 nucleotides from base numbers 1035-2246 was amplified (forward primer: ATGAC AGCCA TCATC, reverse primer: TCAGA CTTTT GTAAT TTG) and sequenced in both directions with six primers. Sequencing was done on an ABI Prism 377 DNA Sequencer using BigDye Terminator Cycle Sequencing (Perkin-Elmer, Foster City, CA, USA). Results were compared to the reference sequence with Sequencher software (Version 3.0, Gene Codes Corporation, Ann Arbor, MI, USA) and BLAST software.
Northern analyses
Total RNA from the exponentially growing cells was isolated using Trizol (GIBCO, Gaitherburg, MD, USA) or RNeasy spin columns (QIAGEN Inc., Santa Clarita, CA, USA). A measure of 10 mg was separated per lane in a 1.2% formaldehyde-agarose gel and transferred to a Hybond-N + membrane (Amersham, Arlington Heights, IL, USA). A 2.3 kb cDNA probe of the human RRM1 gene, a 1.1kb cDNA probe of the human Glyceraldehyde-3 phosphate dehydrogenase (GAPDH) gene, and a 1.2 kb cDNA probe of the human PTEN gene were prepared and labeled with a- [P 32 ] dCTP using commercially available random primer labeling systems. The membrane was hybridized with the respective probe overnight at 651C, washed extensively, and exposed to X-ray film (Kodak, Rochester, NY, USA) at À701C and to phosphor screens (Molecular Dynamics, Sunnyvale, CA, USA). The membrane was stripped and hybridized with the next probe under the same conditions. Signal intensities for the respective bands were measured and normalized to the GAPDH signal.
Real-time quantitative PCR
Total cellular RNA was reverse transcribed with Superscript II (GIBCO). For quantitative real-time PCR, intron-spanning primers were designed. The cDNA amplicon sizes and probe sizes were 95 and 28 bp for RRM1 and 169 and 24 bp for PTEN. Probes were labeled with the fluorescent reporter dye 6-FAM on the 5 0 end and the quencher TAMRA on the 3 0 end. The equivalent of 5 ng total RNA was used as template. For standard curve determination a mixture of cDNAs derived from various cell lines was consistently used in serial dilutions with 20 mg per reaction as the highest concentration. These were done on each plate, and negative controls without template cDNA were also included. Each sample was run in triplicate. Fluorescent emission as a result of cleavage of the probe through exonuclease activity of Taq polymerase was recorded in real time during the PCR reaction using the ABI prism 7700 sequence detection system (PerkinElmer, Foster City, CA, USA). The relative amount of target RNA in a sample specimen was determined by comparing the threshold cycle with the standard curve. The standardized relative amount of target RNA was then determined by dividing the target RNA amount by the 18S rRNA amount (Perkin-Elmer, #4310893E-0203015, VIC-TAMRA-labeled reporter probe). The slopes and correlation coefficients for the standard curves were in the range of (À)4.6 and 0.99 for RRM1, (À)4.5 and 0.99 for PTEN, and (À)3.9 and 0.99 for 18S rRNA.
Western analyses
Total cellular protein was prepared from exponentially growing cells using a lysis buffer (50 mm Tris-HCl, pH 7.5, 250 mm NaCl, 5 mm EDTA, 0.1% Nonidet P40, 5 mm dithiothreitol, 1 mm PMSF and 1 mg/ml aprotinin, 1 mg/ml leupeptin, 0.1 mm sodium orthovanadate), and the protein content was determined with the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA, USA). For the determination of individual protein levels by Western blotting, 100 mg of cellular extract was loaded per lane, separated in SDS polyacrylamide gels, and then transferred to a nitrocellulose membrane (BioRad, Hercules, CA, USA). The membranes were blocked with 5% milk in phosphate-buffered saline (PBS), followed by incubation with primary antibody for 2 h. The primary antibodies were anti-RRM1 monoclonal antibody (Harlan Sera-Lab, Crawley Down, IN, USA), anti-PTEN monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-FAK and anti-FAK-P monoclonal antibodies (Transduction Laboratories, San Diego, CA, USA). After washing in PBS containing 0.1% Tween-20, the membranes were incubated with secondary antibody for 1 h. They were washed again, incubated for 1 min in Renaissance Western Blot Chemiluminescence reagent, and autoradiographed with Kodak X-omat AR films. Signal intensities for the respective bands were measured by densitometry and normalized to the b-actin signal.
Syngeneic animal experiments
Studies were approved by the Institutional Animal Care and Use Committee. A syngeneic mouse lung carcinoma model was used. Line1 is a cell line derived from a bronchioloalveolar cell carcinoma (subtype of lung adenocarcinoma) that spontaneously arose in a Balb/c mouse (Yuhas et al., 1975) . It forms subcutaneous tumors within 2-3 weeks of injection and spontaneously metastasizes to the lung. Female Balb/c mice (3-6 weeks old) were injected each with 100 000 cells suspended in a volume of 200 ml PBS subcutaneously at a single site in the flank area. Subcutaneous tumor formation was monitored by palpation and visual inspection. After 3 and 6 weeks animals were killed, and the lungs, livers, and brains were fixed in 10% phosphatebuffered formalin (4% w/w formaldehyde, pH 6.9-7.1), embedded in paraffin, sectioned into 4 mm thick slices, and stained with hematoxylin and eosin. For survival studies, animals were injected as described. They were closely monitored for discomfort and to ensure adequate access to food and water. The number of days from injection to death was recorded for each animal. The difference in survival between the two groups of mice was tested for statistical significance with the log-rank test. Cadavers were autopsied, and the lungs, livers, and brains examined for metastases as described.
